Prevalence and Outcomes of Thrombophilia in Patients with Acute Pulmonary Embolism

References

• Nagamalesh UM, Prakash VS, Naidu KCK, Sarthak S, Hegde AV, Abhinay T. Acute pulmonary thromboembolism: epidemiology, predictors, and long-term outcome – A single center experience. Indian Heart J. 2017;69:160–164. doi:10.1016/j.ihj.2016.08.010
   PubMedGoogle Scholar
• Ceresetto JM. Venous thromboembolism in Latin America: a review and guide to diagnosis and treatment for primary care. Clinics (Sao Paulo). 2016;71:36–46. doi:10.6061/clinics/2016(01)07
   PubMed Web of Science ®Google Scholar
• White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4–I8. doi:10.1161/01.CIR.0000078468.11849.66
   PubMed Web of Science ®Google Scholar
• Morrone D, Morrone V. Acute pulmonary embolism: focus on the clinical picture. Korean Circ J. 2018;48(5):365–381. doi:10.4070/kcj.2017.0314
   PubMed Web of Science ®Google Scholar
• Vossen CY, Conard J, Fontcuberta J, et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost. 2005;3:459–464. doi:10.1111/jth.2005.3.issue-3
   PubMed Web of Science ®Google Scholar
• McRae S. Pulmonary embolism. Aust Fam Physician. 2010;39:462–466.
   PubMedGoogle Scholar
• Moheimani F, Jackson DE. Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol. 2011;2011:124610. doi:10.5402/2011/124610
   PubMedGoogle Scholar
• Merriman L, Greaves M. Testing for thrombophilia: an evidence-based approach. Postgrad Med J. 2006;82(973):699–704. doi:10.1136/pgmj.2006.048090
   PubMed Web of Science ®Google Scholar
• Canadian Agency for Drugs and Technologies in Health. Effectiveness of Factor V Leiden and Prothrombin Mutation Testing in Patients Presenting with a First Unprovoked Venous Thromboembolic Episode: A Systematic Review and Economic Analysis [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; March, 2015. Available from http://www.ncbi.nlm.nih.gov/books/NBK361450/.
   Google Scholar
• Khan S, Dickerman JD. Hereditary thrombophilia. Thromb J. 2006;4:15. doi:10.1186/1477-9560-4-15
   PubMedGoogle Scholar
• Ali N, Ayyub M, Khan SA. High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident. Pak J Med Sci. 2014;30:1323–1326. doi:10.12669/pjms.306.5878
   PubMed Web of Science ®Google Scholar
• Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med. 2003;138:128–134. doi:10.7326/0003-4819-138-2-200301210-00014
   PubMed Web of Science ®Google Scholar
• Di Minno MN, Ambrosino P, Ageno W, Rosendaal F, Di Minno G, Dentali F. Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies. Thromb Res. 2015;135(5):923–932. doi:10.1016/j.thromres.2015.03.010
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim EK, Kim MS, et al. The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms. PLoS One. 2017;12(10):e0185785. doi:10.1371/journal.pone.0185785
   PubMed Web of Science ®Google Scholar
• Brüwer G, Limperger V, Kenet G, et al. Impact of high risk thrombophilia status on recurrence among children and adults with VTE: an observational multicenter cohort study. Blood Cells Mol Dis. 2016;62:24–31. doi:10.1016/j.bcmd.2016.10.024
   PubMed Web of Science ®Google Scholar
• Bucciarelli P, Rosendaal FR, Tripodi A, et al. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol. 1999;19(4):1026–1033. doi:10.1161/01.ATV.19.4.1026
   PubMed Web of Science ®Google Scholar
• Lee LH, Liu TC, Kuperan P, et al. Hereditary thrombophilia in an unselected cohort of venous thrombosis patients in Singapore. J Clin Pathol. 2011;64:814–817. doi:10.1136/jclinpath-2011-200018
   PubMed Web of Science ®Google Scholar
• Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, van der Meer J. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost. 2009;101(1):93–99. doi:10.1160/TH08-06-0364
   PubMed Web of Science ®Google Scholar
• Rossi E, Za T, Ciminello A, Leone G, De Stefano V. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia. Thromb Haemost. 2008;99:1030–1034. doi:10.1160/TH08-02-0069
   PubMed Web of Science ®Google Scholar
• De Stefano V, Simioni P, Rossi E, et al. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica. 2006;91:695–698.
   PubMed Web of Science ®Google Scholar
• Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998;92(7):2353–2358. doi:10.1182/blood.V92.7.2353
   PubMed Web of Science ®Google Scholar
• Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost. 1999;81(2):198–202. doi:10.1055/s-0037-1614442
   PubMed Web of Science ®Google Scholar
• Pai N, Ghosh K, Shetty S. Cause of deep venous thrombosis and pulmonary embolism in young patients from India as compared with other ethnic groups. Blood Coagul Fibrinolysis. 2012;23:257–261. doi:10.1097/MBC.0b013e3283502961
   PubMed Web of Science ®Google Scholar
• De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87(9):3531–3544. doi:10.1182/blood.V87.9.3531.bloodjournal8793531
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332(14):912–917. doi:10.1056/NEJM199504063321403
   PubMed Web of Science ®Google Scholar
• El-Menyar A, Nabir S, Ahmed N, Asim M, Jabbour G, Al-Thani H. Diagnostic implications of computed tomography pulmonary angiography in patients with pulmonary embolism. Ann Thorac Med. 2016;11(4):269–276. doi:10.4103/1817-1737.191868
   PubMed Web of Science ®Google Scholar
• Al Otair HA, Al-Boukai AA, Ibrahim GF, Al Shaikh MK, Mayet AY, Al-Hajjaj MS. Outcome of pulmonary embolism and clinico-radiological predictors of mortality: experience from a university hospital in Saudi Arabia. Ann Thorac Med. 2014;9:18–22. doi:10.4103/1817-1737.124420
   PubMed Web of Science ®Google Scholar
• Weingarz L, Schwonberg J, Schindewolf M, et al. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry. Br J Haematol. 2013;163:655–665. doi:10.1111/bjh.12575
   PubMed Web of Science ®Google Scholar
• Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation. 2008;118(16):1659–1667. doi:10.1161/CIRCULATIONAHA.108.780759
   PubMed Web of Science ®Google Scholar
• Shafiq A, Lodhi H, Ahmed Z, Bajwa A. Is the pulmonary embolism severity index being routinely used in clinical practice? Thrombosis. 2015;2015:175357. doi:10.1155/2015/175357
   PubMedGoogle Scholar
• Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116:427–433. doi:10.1161/CIRCULATIONAHA.106.680421
   PubMed Web of Science ®Google Scholar
• Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458–462. doi:10.1001/jama.279.6.458
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S–e496S. doi:10.1378/chest.11-2301
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood. 2014;123(12):1794–1801. doi:10.1182/blood-2013-12-512681
   PubMed Web of Science ®Google Scholar
• Pengo V, Lensing AW, Prins MH, et al.; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–2264. doi:10.1056/NEJMoa032274
   PubMed Web of Science ®Google Scholar
• van den Belt AG, Sanson BJ, Simioni P, et al. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med. 1997;157(19):2227–2232. doi:10.1001/archinte.1997.00440400077009
   PubMedGoogle Scholar
• Hron G, Eichinger S, Weltermann A, et al. Family history for venous thromboembolism and the risk for recurrence. Am J Med. 2006;119(1):50–53. doi:10.1016/j.amjmed.2005.04.043
   PubMed Web of Science ®Google Scholar
• Pabinger I, Vossen CY, Lang J, et al. Mortality and inherited thrombophilia: results from the European Prospective Cohort on Thrombophilia. J Thromb Haemost. 2012;10(2):217–222. doi:10.1111/j.1538-7836.2011.04573.x
   PubMed Web of Science ®Google Scholar
• Stevens SM, Woller SC, Bauer KA, et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016;41(1):154–164. doi:10.1007/s11239-015-1316-1
   PubMed Web of Science ®Google Scholar